Award details

Knowledge-based improvement of antibiotic production and discovery:increasing yields from indistrial strains and identifying novel therapeutics targets

ReferenceBB/D525705/1
Principal Investigator / Supervisor Professor Mervyn Bibb
Co-Investigators /
Co-Supervisors
Institution John Innes Centre
DepartmentJohn Innes Centre
Funding typeResearch
Value (£) 58,919
StatusCompleted
TypeResearch Grant
Start date 01/01/2006
End date 31/12/2006
Duration12 months

Abstract

Streptomycetes and their relatives are important sources of pharmaceutically active compounds, supplying many currently used antibiotics. Our laboratory has pioneered the development of genetic and molecular techniques to dissect the complex regulatory mechanisms that control the onset of secondary metabolism in streptomycetes. This knowledge can now be applied to engineer strains with quantitative improvements in antibiotic production. To commercialise this technology it is necessary to perform proof-of-principle experiments in industrially relevant strains. This project will use a novel mass spec-based technology to identify regulatory proteins required for the production of the peptide antibiotic cinnamycin (in partnership with Novacta Biosystems Ltd), the aminoglycoside kanamycin, and the cyclic lipopeptide daptomycin (marketed as CubicinTM). The technology will also be used to identify regulators of virulence in the human pathogen Staphylococcus aureus as a demonstration of our ability to define novel therapeutic targets that will be valuable in the effort to detect new classes of antibiotics.

Summary

unavailable
Committee Closed Committee - Plant & Microbial Sciences (PMS)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Follow-On Fund (FOF) [2004-2015]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file